Introduction The development of new compounds in recent decades has substantially improved the pharmacotherapy of type 2 diabetes (T2D) by improving achievement of metabolic targets while mitigating specific side effects (e.g., weight gain, hypoglycemia) frequently observed in patients treated with traditional hypoglycemic drugs such as insulin and sulfonylureas
Products Mass spectrometry reagents MS/MS controls (C2) Acetylcarnitine Found better price
This can help improve fullness, regulate blood sugar, and support long-term metabolic health such as better blood pressure, triglycerides, waist to hip ratio, cholesterol, etc
Meanwhile, simpler, whole foods like lean proteins, vegetables, and fruits become more satisfying
Ejemplos de estas molculas son inhibidores de mTOR, como la rapamicina